{"title":"Novedades en el laboratorio","description":"\u003cp\u003eCompuestos y formatos de investigación recientemente añadidos, ahora disponibles en la colección de Helixera Labs.\u003c\/p\u003e","products":[{"product_id":"nad-spray","title":"NAD+ — Liquid Spray (750mg)","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eNAD+ Nasal Spray – 750mg (7.5 mg per spray) – Research Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eNAD+ (Nicotinamide Adenine Dinucleotide) Nasal Spray is a ready-to-use liquid formulation designed for researchers investigating intranasal delivery of this essential cellular coenzyme. It is supplied in a convenient nasal spray vial and is studied for its potential to support cellular energy metabolism and neurological research through direct nose-to-brain pathways.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eIn laboratory settings, researchers examine how NAD+ functions as a critical electron carrier in redox reactions and as a substrate for key enzymes such as sirtuins, PARPs, and CD38. The nasal delivery method is of particular interest for its ability to bypass the blood-brain barrier and target central nervous system tissues more efficiently.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearchers commonly study NAD+ Nasal Spray to explore its potential involvement in:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eCellular energy production and mitochondrial function (ATP synthesis)\u003c\/li\u003e\n\u003cli\u003eSirtuin activation and longevity-related signaling pathways\u003c\/li\u003e\n\u003cli\u003eNeuroprotection and cognitive function research\u003c\/li\u003e\n\u003cli\u003eDNA repair mechanisms and genomic stability\u003c\/li\u003e\n\u003cli\u003eRedox balance and oxidative stress regulation\u003c\/li\u003e\n\u003cli\u003eMetabolic regulation including glucose and lipid metabolism\u003c\/li\u003e\n\u003cli\u003eAge-related NAD+ decline and cellular senescence models\u003c\/li\u003e\n\u003cli\u003eBrain-specific delivery and neurological health pathways\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003eAs a foundational coenzyme delivered via nasal spray, NAD+ serves as a critical research tool for investigating metabolic regulation, mitochondrial health, aging processes, and central nervous system applications in controlled laboratory environments.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e📄 \u003ca href=\"https:\/\/www.helixerapeptides.com\/pages\/nad-nicotinamide-adenine-dinucleotide-comprehensive-research-overview-2026\" target=\"_blank\"\u003eRead the Full Research Overview →\u003c\/a\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemical Name\u003c\/strong\u003e: Nicotinamide Adenine Dinucleotide (NAD+)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS Number\u003c\/strong\u003e: 53-84-9\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₂₁H₂₆N₇O₁₄P₂\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: ≈663.43 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm\u003c\/strong\u003e: Liquid nasal spray solution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTotal Content\u003c\/strong\u003e: 750mg per vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration\u003c\/strong\u003e: 7.5 mg per spray\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity\u003c\/strong\u003e: Third-party lab tested – COA available upon request\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e: Store at -20°C or lower, protected from light and moisture. Once opened, follow standard laboratory protocols for liquid stability and use within recommended timeframes.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e: Nasal Spray\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u003c\/p\u003e","brand":"Helixera Labs LLC","offers":[{"title":"Default Title","offer_id":46747408171185,"sku":null,"price":125.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/372pi.jpg?v=1781155651"},{"product_id":"semax-spray","title":"SEMAX — Liquid Spray (30mg)","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eSemax Nasal Spray – 30mg (300 mcg per spray) – Research Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eSemax Nasal Spray is a ready-to-use liquid formulation of the synthetic heptapeptide Semax, designed for researchers investigating intranasal delivery and direct nose-to-brain pathways. It is supplied in a convenient research nasal spray vial and is studied for its neuroprotective, nootropic, and neuromodulatory effects.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eIn laboratory settings, researchers examine how Semax influences brain-derived neurotrophic factor (BDNF) expression, neurotransmitter systems, and neuronal survival. The nasal spray delivery method is of particular interest due to its ability to bypass the blood-brain barrier and target central nervous system tissues more efficiently.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearchers commonly study Semax Nasal Spray to explore its potential involvement in:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eCognitive enhancement, memory formation, and learning processes\u003c\/li\u003e\n\u003cli\u003eNeuroprotection and neuronal survival signaling\u003c\/li\u003e\n\u003cli\u003eBDNF expression and neuroplasticity mechanisms\u003c\/li\u003e\n\u003cli\u003eStroke recovery and ischemic brain injury models\u003c\/li\u003e\n\u003cli\u003eAttention, focus, and mental performance pathways\u003c\/li\u003e\n\u003cli\u003eStress response and anxiety-related signaling\u003c\/li\u003e\n\u003cli\u003eOptic nerve and retinal neuroprotection\u003c\/li\u003e\n\u003cli\u003eBrain-specific delivery and neurological recovery research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003eAs a potent ACTH-derived nootropic peptide delivered via nasal spray, Semax serves as a valuable research tool for investigating cognitive function, neuroprotection, brain plasticity, and neuromodulation through intranasal administration in controlled laboratory environments.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e📄 \u003ca href=\"https:\/\/www.helixerapeptides.com\/pages\/semax-comprehensive-research-overview-2026\" target=\"_blank\"\u003eRead the Full Research Overview →\u003c\/a\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemical Name\u003c\/strong\u003e: Semax\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS Number\u003c\/strong\u003e: 80714-61-0\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₃₇H₅₁N₉O₁₀S\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: ≈813.92 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm\u003c\/strong\u003e: Liquid nasal spray solution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTotal Content\u003c\/strong\u003e: 30mg per vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration\u003c\/strong\u003e: 300 mcg per spray\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity\u003c\/strong\u003e: Third-party lab tested – COA available upon request\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e: Store at -20°C or lower, protected from light and moisture. Once opened, follow standard laboratory protocols for liquid peptide stability and use within recommended timeframes.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e: Nasal Spray\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u003c\/p\u003e","brand":"Helixera Labs LLC","offers":[{"title":"Default Title","offer_id":46747412496561,"sku":null,"price":109.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/GQTuw.jpg?v=1781155596"},{"product_id":"selank-spray","title":"SELANK — Liquid Spray (30mg)","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eSelank Nasal Spray – 30mg (300 mcg per spray) – Research Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eSelank Nasal Spray is a ready-to-use liquid formulation of the synthetic heptapeptide Selank, designed for researchers investigating intranasal delivery and direct nose-to-brain pathways. It is supplied in a convenient research nasal spray vial and is studied for its anxiolytic, nootropic, and neuroprotective properties.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eIn laboratory settings, researchers examine how Selank modulates GABAergic transmission, influences serotonin and dopamine systems, and increases BDNF (brain-derived neurotrophic factor) expression. The nasal spray delivery method is of particular interest for its ability to bypass the blood-brain barrier and target central nervous system tissues more efficiently.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearchers commonly study Selank Nasal Spray to explore its potential involvement in:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eAnxiety reduction and anxiolytic pathways without sedative effects\u003c\/li\u003e\n\u003cli\u003eCognitive enhancement, memory, and mental performance\u003c\/li\u003e\n\u003cli\u003eNeuroprotection and neuronal survival signaling\u003c\/li\u003e\n\u003cli\u003eBDNF expression and neuroplasticity mechanisms\u003c\/li\u003e\n\u003cli\u003eStress response and HPA axis modulation\u003c\/li\u003e\n\u003cli\u003eImmune system regulation within the central nervous system\u003c\/li\u003e\n\u003cli\u003eMood stabilization and emotional balance research\u003c\/li\u003e\n\u003cli\u003eBrain-specific delivery for neurological and psychological models\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003eAs a tuftsin-derived heptapeptide delivered via nasal spray, Selank serves as a valuable research tool for investigating anxiety, cognition, neuroprotection, and brain-immune interactions through intranasal administration in controlled laboratory environments.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e📄 \u003ca href=\"https:\/\/www.helixerapeptides.com\/pages\/selank-comprehensive-research-overview-2026\" target=\"_blank\"\u003eRead the Full Research Overview →\u003c\/a\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemical Name\u003c\/strong\u003e: Selank\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS Number\u003c\/strong\u003e: 129954-34-3\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₃₃H₅₇N₁₁O₉\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: ≈751.87 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm\u003c\/strong\u003e: Liquid nasal spray solution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTotal Content\u003c\/strong\u003e: 30mg per vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration\u003c\/strong\u003e: 300 mcg per spray\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity\u003c\/strong\u003e: Third-party lab tested – COA available upon request\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e: Store at -20°C or lower, protected from light and moisture. Once opened, follow standard laboratory protocols for liquid peptide stability and use within recommended timeframes.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e: Nasal Spray\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u003c\/p\u003e","brand":"Helixera Labs LLC","offers":[{"title":"Default Title","offer_id":46747412660401,"sku":null,"price":109.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/selank_44f1295a-6a52-4f21-a34b-18a52e08a9c9.jpg?v=1781155510"},{"product_id":"oxytocin-acetate-spray-525iu","title":"Oxytocin Acetate — Liquid Spray (525iu)","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eOxytocin Acetate Nasal Spray – 525 IU (7 IU per spray) – Research Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eOxytocin Acetate Nasal Spray is a ready-to-use liquid formulation of the neuropeptide hormone oxytocin, designed for researchers investigating intranasal delivery and direct nose-to-brain pathways. It is supplied in a convenient research nasal spray vial and is widely studied for its profound effects on social behavior, emotional regulation, and neuroendocrine signaling.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eIn laboratory settings, researchers examine how oxytocin binds to oxytocin receptors in the brain to influence trust, empathy, social bonding, and stress response systems. The nasal spray delivery method is of particular interest because it allows oxytocin to bypass the blood-brain barrier more effectively and target central nervous system receptors.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearchers commonly study Oxytocin Acetate Nasal Spray to explore its potential involvement in:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eSocial bonding, trust, and interpersonal behavior pathways\u003c\/li\u003e\n\u003cli\u003eEmotional regulation and empathy mechanisms\u003c\/li\u003e\n\u003cli\u003eStress response and HPA axis modulation\u003c\/li\u003e\n\u003cli\u003eAnxiety reduction and fear extinction processes\u003c\/li\u003e\n\u003cli\u003eMaternal behavior and reproductive signaling\u003c\/li\u003e\n\u003cli\u003eAutism spectrum disorder and social cognition research\u003c\/li\u003e\n\u003cli\u003ePain perception and analgesic pathways\u003c\/li\u003e\n\u003cli\u003eBrain-specific delivery for neuropsychiatric and behavioral models\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003eAs a key neuropeptide involved in social and emotional processing, Oxytocin Acetate Nasal Spray serves as a valuable research tool for investigating social neuroscience, emotional regulation, stress biology, and neuropsychiatric conditions through intranasal administration in controlled laboratory environments.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e📄 \u003ca href=\"https:\/\/www.helixerapeptides.com\/pages\/oxytocin-acetate-comprehensive-research-overview-2026\" target=\"_blank\"\u003eRead the Full Research Overview →\u003c\/a\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemical Name\u003c\/strong\u003e: Oxytocin Acetate\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS Number\u003c\/strong\u003e: 6233-83-6\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₄₅H₇₀N₁₂O₁₄S₂\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: ≈1067.25 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm\u003c\/strong\u003e: Liquid nasal spray solution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTotal Content\u003c\/strong\u003e: 525 IU per vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration\u003c\/strong\u003e: 7 IU per spray\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity\u003c\/strong\u003e: Third-party lab tested – COA available upon request\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e: Store at -20°C or lower, protected from light and moisture. Once opened, follow standard laboratory protocols for liquid peptide stability and use within recommended timeframes.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e: Nasal Spray\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u003c\/p\u003e","brand":"Helixera Labs LLC","offers":[{"title":"Default Title","offer_id":46747412693169,"sku":null,"price":94.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/9DRBu.jpg?v=1781155453"},{"product_id":"ara-290-powder","title":"ARA-290 — Powder","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eARA-290 Lyophilized Powder – Vial – Research Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eARA-290 (Cibinetide) is a synthetic 11-amino-acid peptide derived from erythropoietin (EPO) that selectively activates the innate repair receptor (IRR). It is supplied as a lyophilized powder in a sealed research vial and is studied for its tissue-protective, anti-inflammatory, and neuroprotective properties without the hematopoietic (blood-forming) effects associated with full EPO.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eIn laboratory settings, researchers examine how ARA-290 binds to the IRR to reduce inflammation, protect tissues from injury, and promote healing through mitochondrial stabilization and anti-apoptotic signaling.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearchers commonly study ARA-290 to explore its potential involvement in:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eTissue protection and cytoprotective signaling pathways\u003c\/li\u003e\n\u003cli\u003eReduction of inflammation and pro-inflammatory cytokines\u003c\/li\u003e\n\u003cli\u003eNeuropathic pain and nerve damage repair mechanisms\u003c\/li\u003e\n\u003cli\u003eDiabetic complications and small fiber neuropathy models\u003c\/li\u003e\n\u003cli\u003eMitochondrial function and cellular energy preservation\u003c\/li\u003e\n\u003cli\u003eWound healing and organ protection in injury models\u003c\/li\u003e\n\u003cli\u003eNeuroprotection and central nervous system repair\u003c\/li\u003e\n\u003cli\u003eChronic inflammatory and autoimmune-related research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003eAs a selective erythropoietin-derived peptide, ARA-290 serves as a valuable research tool for investigating tissue repair, neuropathic pain, mitochondrial medicine, and non-hematopoietic protective signaling in controlled laboratory environments.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e📄 \u003ca href=\"https:\/\/www.helixerapeptides.com\/pages\/ara-290-cibinetide-comprehensive-research-overview-2026\" target=\"_blank\"\u003eRead the Full Research Overview →\u003c\/a\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemical Name\u003c\/strong\u003e: ARA-290 (Cibinetide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS Number\u003c\/strong\u003e: 1208243-50-8\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₅₁H₈₄N₁₆O₂₁\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: ≈1257.3 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm\u003c\/strong\u003e: Lyophilized powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppearance\u003c\/strong\u003e: White to off-white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity\u003c\/strong\u003e: ≥99% (HPLC) – COA available upon request\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e: Store at -20°C or lower, protected from light and moisture. Reconstitute using standard laboratory peptide protocols.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e: Lyophilized Vial\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u003c\/p\u003e","brand":"Helixera Labs LLC","offers":[{"title":"10mg","offer_id":47335323795633,"sku":null,"price":49.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/ara290.jpg?v=1780727745"},{"product_id":"kisspeptin-powder","title":"Kisspeptin - Powder","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eKisspeptin Lyophilized Powder – Vial – Research Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eKisspeptin is a naturally occurring neuropeptide that plays a critical role in reproductive endocrinology. It is supplied as a lyophilized powder in a sealed research vial and is widely studied for its potent regulatory effects on the hypothalamic-pituitary-gonadal (HPG) axis.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eIn laboratory settings, researchers examine how Kisspeptin binds to the KISS1R (GPR54) receptor to stimulate the release of gonadotropin-releasing hormone (GnRH). This upstream signaling leads to increased secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearchers commonly study Kisspeptin to explore its potential involvement in:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eRegulation of the hypothalamic-pituitary-gonadal (HPG) axis\u003c\/li\u003e\n\u003cli\u003eGnRH pulse generation and reproductive hormone signaling\u003c\/li\u003e\n\u003cli\u003eLH and FSH secretion and gonadal function\u003c\/li\u003e\n\u003cli\u003ePuberty onset and reproductive maturation processes\u003c\/li\u003e\n\u003cli\u003eFertility and hormonal balance pathways\u003c\/li\u003e\n\u003cli\u003eEnergy balance, metabolism, and reproductive function integration\u003c\/li\u003e\n\u003cli\u003eNeuroendocrine signaling in response to environmental and metabolic cues\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003eAs a key upstream regulator of reproductive hormones, Kisspeptin serves as an essential research tool for investigating endocrine signaling, fertility mechanisms, and neuroendocrine control of reproduction in controlled laboratory environments.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e📄 \u003ca href=\"https:\/\/www.helixerapeptides.com\/pages\/kisspeptin-comprehensive-research-overview-2026\" target=\"_blank\"\u003eRead the Full Research Overview →\u003c\/a\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eChemical Name\u003c\/strong\u003e: Kisspeptin\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS Number\u003c\/strong\u003e: 374675-21-5\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Formula\u003c\/strong\u003e: C₆₃H₈₃N₁₇O₁₄\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: ≈1302.45 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm\u003c\/strong\u003e: Lyophilized powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppearance\u003c\/strong\u003e: White to off-white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity\u003c\/strong\u003e: ≥99% (HPLC) – COA available upon request\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e: Store at -20°C or lower, protected from light and moisture. Reconstitute using standard laboratory peptide protocols.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e: Lyophilized Vial\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u003c\/p\u003e","brand":"Helixera Labs LLC","offers":[{"title":"10mg","offer_id":47335323697329,"sku":null,"price":44.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/kiss.jpg?v=1780727744"},{"product_id":"b-12-mic-lipo-pure","title":"B-12 MIC | LIPO PURE","description":"\u003cstyle\u003e[stylesheet-group=\"0\"]{}\nbody{margin:0;}\nbutton::-moz-focus-inner,input::-moz-focus-inner{border:0;padding:0;}\nhtml{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;-webkit-tap-highlight-color:rgba(0,0,0,0);}\ninput::-webkit-search-cancel-button,input::-webkit-search-decoration,input::-webkit-search-results-button,input::-webkit-search-results-decoration{display:none;}\n[stylesheet-group=\"1\"]{}\n.css-146c3p1{background-color:rgba(0,0,0,0.00);border:0 solid black;box-sizing:border-box;color:rgba(0,0,0,1.00);display:inline;font:14px -apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif;list-style:none;margin:0px;padding:0px;position:relative;text-align:start;text-decoration:none;white-space:pre-wrap;word-wrap:break-word;}\n.css-175oi2r{align-items:stretch;background-color:rgba(0,0,0,0.00);border:0 solid black;box-sizing:border-box;display:flex;flex-basis:auto;flex-direction:column;flex-shrink:0;list-style:none;margin:0px;min-height:0px;min-width:0px;padding:0px;position:relative;text-decoration:none;z-index:0;}\n.css-1jxf684{background-color:rgba(0,0,0,0.00);border:0 solid black;box-sizing:border-box;color:inherit;display:inline;font:inherit;list-style:none;margin:0px;padding:0px;position:relative;text-align:inherit;text-decoration:none;white-space:inherit;word-wrap:break-word;}\n.css-9pa8cd{bottom:0px;height:100%;left:0px;opacity:0;position:absolute;right:0px;top:0px;width:100%;z-index:-1;}\n[stylesheet-group=\"2\"]{}\n.r-13awgt0{flex:1;}\n.r-17gur6a{border-bottom-left-radius:0px;border-bottom-right-radius:0px;border-top-left-radius:0px;border-top-right-radius:0px;}\n.r-1867qdf{border-bottom-left-radius:16px;border-bottom-right-radius:16px;border-top-left-radius:16px;border-top-right-radius:16px;}\n.r-1adg3ll{display:block;}\n.r-1fuqb1j{border-bottom-left-radius:24px;border-bottom-right-radius:24px;border-top-left-radius:24px;border-top-right-radius:24px;}\n.r-1jkafct{border-bottom-left-radius:2px;border-bottom-right-radius:2px;border-top-left-radius:2px;border-top-right-radius:2px;}\n.r-1phboty{border-bottom-style:solid;border-left-style:solid;border-right-style:solid;border-top-style:solid;}\n.r-1pp0k63{border-bottom-left-radius:0.01px;border-bottom-right-radius:0.01px;border-top-left-radius:0.01px;border-top-right-radius:0.01px;}\n.r-1udh08x{overflow-x:hidden;overflow-y:hidden;}\n.r-4iw3lz{border-bottom-width:0;border-left-width:0;border-right-width:0;border-top-width:0;}\n.r-4qtqp9{display:inline-block;}\n.r-6koalj{display:flex;}\n.r-bztko3{overflow-x:visible;overflow-y:visible;}\n.r-crgep1{margin:0px;}\n.r-hvic4v{display:none;}\n.r-krxsd3{display:-webkit-box;}\n.r-rs99b7{border-bottom-width:1px;border-left-width:1px;border-right-width:1px;border-top-width:1px;}\n.r-sdzlij{border-bottom-left-radius:9999px;border-bottom-right-radius:9999px;border-top-left-radius:9999px;border-top-right-radius:9999px;}\n.r-t60dpp{padding:0px;}\n.r-wwvuq4{padding:0;}\n.r-xoduu5{display:inline-flex;}\n.r-ywje51{margin:auto;}\n.r-z2wwpe{border-bottom-left-radius:4px;border-bottom-right-radius:4px;border-top-left-radius:4px;border-top-right-radius:4px;}\n[stylesheet-group=\"2.1\"]{}\n.r-1559e4e{padding-bottom:2px;padding-top:2px;}\n.r-1fkl15p{padding-left:32px;padding-right:32px;}\n.r-3o4zer{padding-left:12px;padding-right:12px;}\n.r-3pj75a{padding-left:16px;padding-right:16px;}\n.r-cxgwc0{padding-left:24px;padding-right:24px;}\n.r-dd0y9b{padding-bottom:20px;padding-top:20px;}\n.r-ddtstp{margin-bottom:0px;margin-top:0px;}\n.r-dp7rxi{padding-bottom:40px;padding-top:40px;}\n.r-f8sm7e{margin-left:auto;margin-right:auto;}\n.r-n7gxbd{padding-left:4px;padding-right:4px;}\n.r-s49dbf{margin-bottom:1px;margin-top:1px;}\n.r-sjygvo{padding-left:1em;padding-right:1em;}\n[stylesheet-group=\"2.2\"]{}\n.r-15peodp{right:-9999px;}\n.r-19qo34d{left:-9999px;}\n.r-1ca1ndr{margin-left:0.5em;}\n.r-1ez5h0i{margin-left:4px;}\n.r-1gs4q39{margin-right:4px;}\n.r-1kkk96v{margin-left:8px;}\n.r-1kpi4qh{margin-left:0.075em;}\n.r-1l2kgy{margin-right:0.5em;}\n.r-1q6cnnd{right:-2px;}\n.r-1wron08{margin-right:8px;}\n.r-3t4u6i{margin-left:2px;}\n.r-45ll9u{left:50%;}\n.r-5f1w11{left:-2px;}\n.r-k4bwe5{margin-right:0.075em;}\n.r-o59np7{padding-right:8px;}\n.r-ocobd0{right:50%;}\n.r-qjj4hq{padding-left:8px;}\n.r-x1x4zq{margin-right:2px;}\n[stylesheet-group=\"3\"]{}\n.r-105ug2t{pointer-events:auto!important;}\n.r-109y4c4{height:1px;}\n.r-10ef88u{min-width:700px;}\n.r-10ptun7{height:16px;}\n.r-10v3vxq{transform:scaleX(-1);}\n.r-117bsoe{margin-bottom:20px;}\n.r-11c0sde{margin-top:24px;}\n.r-11f8fnl{background-color:rgba(180,180,182,0.50);}\n.r-11j9u27{visibility:hidden;}\n.r-1202g5r{height:90vh;}\n.r-12181gd{box-shadow:0 0 2px rgba(0,0,0,0.03) inset;}\n.r-1279nm1{min-height:400px;}\n.r-12hfotv{width:700px;}\n.r-12sks89{min-height:22px;}\n.r-12vffkv\u003e*{pointer-events:auto;}\n.r-12vffkv{pointer-events:none!important;}\n.r-12ym1je{width:18px;}\n.r-135wba7{line-height:24px;}\n.r-13qz1uu{width:100%;}\n.r-13wfysu{-webkit-text-decoration-line:none;text-decoration-line:none;}\n.r-146iojx{max-width:300px;}\n.r-1472mwg{height:24px;}\n.r-14j79pv{color:rgba(83,100,113,1.00);}\n.r-14lw9ot{background-color:rgba(255,255,255,1.00);}\n.r-158ssxm{max-height:calc(64px * 15);}\n.r-15ysp7h{min-height:32px;}\n.r-16dba41{font-weight:400;}\n.r-16y2uox{flex-grow:1;}\n.r-176fswd{transform:translateX(-50%) translateY(-50%);}\n.r-1777fci{justify-content:center;}\n.r-17bb2tj{animation-duration:0.75s;}\n.r-17gznlh{animation-name:r-t2lo5v;}\n.r-17leim2{background-repeat:repeat;}\n.r-17s6mgv{justify-content:flex-end;}\n.r-18jsvk2{color:rgba(15,20,25,1.00);}\n.r-18tzken{width:56px;}\n.r-18u37iz{flex-direction:row;}\n.r-18yzcnr{height:22px;}\n.r-19qs0lw{animation-name:r-1qpf3yi;}\n.r-19wmn03{width:20px;}\n.r-19yznuf{min-height:52px;}\n.r-1abnn5w{animation-play-state:paused;}\n.r-1acpoxo{width:36px;}\n.r-1ad0z5i{word-break:break-all;}\n.r-1awozwy{align-items:center;}\n.r-1b43r93{font-size:14px;}\n.r-1betnmo{max-width:672px;}\n.r-1blnp2b{width:72px;}\n.r-1blvdjr{font-size:23px;}\n.r-1ceczpf{min-height:24px;}\n.r-1cwl3u0{line-height:16px;}\n.r-1d2f490{left:0px;}\n.r-1ddef8g{-webkit-text-decoration-line:underline;text-decoration-line:underline;}\n.r-1dn12g7{line-height:48px;}\n.r-1dum35f{-moz-transition-property:opacity, height;-webkit-transition-property:opacity, height;transition-property:opacity, height;}\n.r-1ebb2ja{list-style:none;}\n.r-1ff274t{text-align:right;}\n.r-1ffj0ar{background-color:rgba(0,0,0,0.40);}\n.r-1fu8b7j{height:712px;}\n.r-1g83rmp{animation-name:r-7bj9g2;}\n.r-1gkfh8e{font-size:11px;}\n.r-1h0z5md{justify-content:flex-start;}\n.r-1h8ys4a{padding-top:4px;}\n.r-1habvwh{align-items:flex-start;}\n.r-1hjwoze{height:18px;}\n.r-1iln25a{word-wrap:normal;}\n.r-1inkyih{font-size:17px;}\n.r-1ipicw7{width:300px;}\n.r-1iusvr4{flex-basis:0px;}\n.r-1janqcz{width:16px;}\n.r-1jaylin{width:-webkit-max-content;width:-moz-max-content;width:max-content;}\n.r-1k78y06{font-family:Tahoma, Arial, sans-serif;}\n.r-1kihuf0{align-self:center;}\n.r-1ldzwu0{animation-timing-function:linear;}\n.r-1loqt21{cursor:pointer;}\n.r-1mlwlqe{flex-basis:auto;}\n.r-1mrlafo{background-position:0;}\n.r-1muvv40{animation-iteration-count:infinite;}\n.r-1mwlp6a{height:56px;}\n.r-1nao33i{color:rgba(231,233,234,1.00);}\n.r-1niwhzg{background-color:rgba(0,0,0,0.00);}\n.r-1ny4l3l{outline-style:none;}\n.r-1oifz5y{background-color:rgba(170,17,0,1.00);}\n.r-1oszu61{align-items:stretch;}\n.r-1otgn73{touch-action:manipulation;}\n.r-1p0dtai{bottom:0px;}\n.r-1pi2tsx{height:100%;}\n.r-1pjcn9w{max-width:80vw;}\n.r-1potc6q{top:5%;}\n.r-1ps3wis{min-width:44px;}\n.r-1pz39u2{align-self:stretch;}\n.r-1qd0xha{font-family:-apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif;}\n.r-1qi8awa{min-width:36px;}\n.r-1r5jyh0{min-height:130px;}\n.r-1r8g8re{height:36px;}\n.r-1s2hp8q{min-height:26px;}\n.r-1sxrcry{background-size:auto;}\n.r-1tl8opc{font-family:\"Segoe UI\",Meiryo,system-ui,-apple-system,BlinkMacSystemFont,sans-serif;}\n.r-1to6hqq{background-color:rgba(255,212,0,1.00);}\n.r-1tsuqlv{max-height:100vh;}\n.r-1ttztb7{text-align:inherit;}\n.r-1udbk01{text-overflow:ellipsis;}\n.r-1v2oles{top:50%;}\n.r-1vmecro{direction:rtl;}\n.r-1vr29t4{font-weight:800;}\n.r-1wb8bfx{text-decoration-thickness:2px;}\n.r-1wbh5a2{flex-shrink:1;}\n.r-1wvb978{font-feature-settings:'ss01' on;}\n.r-1wyyakw{z-index:-1;}\n.r-1xcajam{position:fixed;}\n.r-1xfddsp{min-height:300px;}\n.r-1xk2f4g{clip:rect(1px, 1px, 1px, 1px);}\n.r-1xnzce8{-moz-user-select:text;-webkit-user-select:text;user-select:text;}\n.r-1xvli5t{height:1.25em;}\n.r-1y7e96w{min-width:22px;}\n.r-1ye8kvj{max-width:600px;}\n.r-1yef0xd{animation-name:r-11cv4x;}\n.r-1yjpyg1{font-size:31px;}\n.r-1ykxob0{top:60%;}\n.r-2o02ov{margin-top:40px;}\n.r-2tavb8{background-color:rgba(0,0,0,0.60);}\n.r-2yi16{min-height:36px;}\n.r-36ujnk{font-style:italic;}\n.r-37tt59{line-height:32px;}\n.r-3s2u2q{white-space:nowrap;}\n.r-417010{z-index:0;}\n.r-4gszlv{background-size:cover;}\n.r-4hwcpe{font-family:Vazirmatn, Tahoma, Arial, sans-serif;}\n.r-4wgw6l{min-width:32px;}\n.r-54znze{color:rgba(239,243,244,1.00);}\n.r-56xrmm{line-height:12px;}\n.r-6026j{background-color:rgba(255,255,255,0.85);}\n.r-633pao{pointer-events:none!important;}\n.r-6416eg{-moz-transition-property:background-color, box-shadow;-webkit-transition-property:background-color, box-shadow;transition-property:background-color, box-shadow;}\n.r-64el8z{min-width:52px;}\n.r-68jxh1{min-width:500px;}\n.r-7h7f8p{max-width:100vw;}\n.r-7q8q6z{cursor:default;}\n.r-8akbws{-webkit-box-orient:vertical;}\n.r-8jfcpp{top:-2px;}\n.r-92ng3h{width:1px;}\n.r-a023e6{font-size:15px;}\n.r-adyw6z{font-size:20px;}\n.r-agouwx{transform:translateZ(0);}\n.r-ah5dr5\u003e*{pointer-events:none;}\n.r-ah5dr5{pointer-events:auto!important;}\n.r-aqfbo4{backface-visibility:hidden;}\n.r-b88u0q{font-weight:700;}\n.r-bcqeeo{min-width:0px;}\n.r-bnwqim{position:relative;}\n.r-bt1l66{min-height:20px;}\n.r-bvlit7{margin-bottom:-12px;}\n.r-clrlgt{animation-name:r-imtty0;}\n.r-deolkf{box-sizing:border-box;}\n.r-dflpy8{height:1.2em;}\n.r-dnmrzs{max-width:100%;}\n.r-ehq7j7{background-size:contain;}\n.r-emqnss{transform:translateZ(0px);}\n.r-eqz5dr{flex-direction:column;}\n.r-ero68b{min-height:40px;}\n.r-fa1dwr{animation-timing-function:cubic-bezier(0.25, 0.1, 0.25, 1);}\n.r-fdjqy7{text-align:left;}\n.r-fm7h5w{font-family:\"TwitterChirpExtendedHeavy\",\"Verdana\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif;}\n.r-g6jmlv{width:100vw;}\n.r-gf0ln{-webkit-filter:brightness(1);filter:brightness(1);}\n.r-h9hxbl{width:1.2em;}\n.r-htvplk{min-width:600px;}\n.r-icoktb{opacity:0.5;}\n.r-ifefl9{min-height:0px;}\n.r-impgnl{transform:translateX(50%) translateY(-50%);}\n.r-iphfwy{padding-bottom:4px;}\n.r-ipm5af{top:0px;}\n.r-jmul1s{transform:scale(1.1);}\n.r-jwli3a{color:rgba(255,255,255,1.00);}\n.r-kemksi{background-color:rgba(0,0,0,1.00);}\n.r-kwpbio{height:650px;}\n.r-lp5zef{min-width:24px;}\n.r-lrsllp{width:24px;}\n.r-lrvibr{-moz-user-select:none;-webkit-user-select:none;user-select:none;}\n.r-lrx3fh{width:500px;}\n.r-m6rgpd{vertical-align:text-bottom;}\n.r-majxgm{font-weight:500;}\n.r-n1ft60{dynamic-range-limit:standard;}\n.r-n6v787{font-size:13px;}\n.r-nhe8su{animation-duration:0.5s;}\n.r-nvplwv{animation-timing-function:ease-out;}\n.r-nwxazl{line-height:40px;}\n.r-o7ynqc{transition-duration:0.2s;}\n.r-obd0qt{align-items:flex-end;}\n.r-orgf3d{opacity:0;}\n.r-peo1c{min-height:44px;}\n.r-poiln3{font-family:inherit;}\n.r-pp5qcn{vertical-align:-20%;}\n.r-q4m81j{text-align:center;}\n.r-qlhcfr{font-size:0.001px;}\n.r-qvk6io{line-height:0px;}\n.r-qvutc0{word-wrap:break-word;}\n.r-rjixqe{line-height:20px;}\n.r-rki7wi{bottom:12px;}\n.r-rsyp9y{max-height:90vh;}\n.r-s67bdx{font-size:48px;}\n.r-sb58tz{max-width:1000px;}\n.r-tjvw6i{text-decoration-thickness:1px;}\n.r-u6sd8q{background-repeat:no-repeat;}\n.r-u8s1d{position:absolute;}\n.r-ueyrd6{line-height:36px;}\n.r-uho16t{font-size:34px;}\n.r-uz7a3o{min-width:650px;}\n.r-vkv6oe{min-width:40px;}\n.r-vqxq0j{border:0 solid black;}\n.r-vrz42v{line-height:28px;}\n.r-vvn4in{background-position:center;}\n.r-wy61xf{height:72px;}\n.r-x3cy2q{background-size:100% 100%;}\n.r-x572qd{background-color:rgba(247,249,249,1.00);}\n.r-xigjrr{-webkit-filter:blur(4px);filter:blur(4px);}\n.r-yc9v9c{width:22px;}\n.r-yn5ncy{animation-fill-mode:both;}\n.r-yy2aun{font-size:26px;}\n.r-yyyyoo{fill:currentcolor;}\n.r-z2knda{transition-timing-function:ease;}\n.r-z7pwl0{max-width:700px;}\n.r-z80fyv{height:20px;}\n.r-zchlnj{right:0px;}\n@-webkit-keyframes r-11cv4x{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}\n@-webkit-keyframes r-1qpf3yi{0%{opacity:0;transform:scale3d(0.92, 0.92, 1);}100%{opacity:1;transform:scale3d(1, 1, 1);}}\n@-webkit-keyframes r-7bj9g2{0%{opacity:1;transform:scale3d(1, 1, 1);}100%{opacity:0;transform:scale3d(0.92, 0.92, 1);}}\n@-webkit-keyframes r-imtty0{0%{opacity:0;}100%{opacity:1;}}\n@-webkit-keyframes r-t2lo5v{0%{opacity:1;}100%{opacity:0;}}\n@keyframes r-11cv4x{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}\n@keyframes r-1qpf3yi{0%{opacity:0;transform:scale3d(0.92, 0.92, 1);}100%{opacity:1;transform:scale3d(1, 1, 1);}}\n@keyframes r-7bj9g2{0%{opacity:1;transform:scale3d(1, 1, 1);}100%{opacity:0;transform:scale3d(0.92, 0.92, 1);}}\n@keyframes r-imtty0{0%{opacity:0;}100%{opacity:1;}}\n@keyframes r-t2lo5v{0%{opacity:1;}100%{opacity:0;}}\n.r-3x5c00{position:absolute;visibility:hidden;top:0;width:50px;pointer-events:none}\n.r-3x5c00.loaded{visibility:visible;top:50vh;width:50px}\u003c\/style\u003e\n\u003cstyle\u003e[stylesheet-group=\"0\"]{}\nbody{margin:0;}\nbutton::-moz-focus-inner,input::-moz-focus-inner{border:0;padding:0;}\nhtml{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;-webkit-tap-highlight-color:rgba(0,0,0,0);}\ninput::-webkit-search-cancel-button,input::-webkit-search-decoration,input::-webkit-search-results-button,input::-webkit-search-results-decoration{display:none;}\n[stylesheet-group=\"1\"]{}\n.css-146c3p1{background-color:rgba(0,0,0,0.00);border:0 solid black;box-sizing:border-box;color:rgba(0,0,0,1.00);display:inline;font:14px -apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif;list-style:none;margin:0px;padding:0px;position:relative;text-align:start;text-decoration:none;white-space:pre-wrap;word-wrap:break-word;}\n.css-175oi2r{align-items:stretch;background-color:rgba(0,0,0,0.00);border:0 solid black;box-sizing:border-box;display:flex;flex-basis:auto;flex-direction:column;flex-shrink:0;list-style:none;margin:0px;min-height:0px;min-width:0px;padding:0px;position:relative;text-decoration:none;z-index:0;}\n.css-1jxf684{background-color:rgba(0,0,0,0.00);border:0 solid black;box-sizing:border-box;color:inherit;display:inline;font:inherit;list-style:none;margin:0px;padding:0px;position:relative;text-align:inherit;text-decoration:none;white-space:inherit;word-wrap:break-word;}\n.css-9pa8cd{bottom:0px;height:100%;left:0px;opacity:0;position:absolute;right:0px;top:0px;width:100%;z-index:-1;}\n[stylesheet-group=\"2\"]{}\n.r-13awgt0{flex:1;}\n.r-17gur6a{border-bottom-left-radius:0px;border-bottom-right-radius:0px;border-top-left-radius:0px;border-top-right-radius:0px;}\n.r-1867qdf{border-bottom-left-radius:16px;border-bottom-right-radius:16px;border-top-left-radius:16px;border-top-right-radius:16px;}\n.r-1adg3ll{display:block;}\n.r-1fuqb1j{border-bottom-left-radius:24px;border-bottom-right-radius:24px;border-top-left-radius:24px;border-top-right-radius:24px;}\n.r-1jkafct{border-bottom-left-radius:2px;border-bottom-right-radius:2px;border-top-left-radius:2px;border-top-right-radius:2px;}\n.r-1phboty{border-bottom-style:solid;border-left-style:solid;border-right-style:solid;border-top-style:solid;}\n.r-1pp0k63{border-bottom-left-radius:0.01px;border-bottom-right-radius:0.01px;border-top-left-radius:0.01px;border-top-right-radius:0.01px;}\n.r-1udh08x{overflow-x:hidden;overflow-y:hidden;}\n.r-4iw3lz{border-bottom-width:0;border-left-width:0;border-right-width:0;border-top-width:0;}\n.r-4qtqp9{display:inline-block;}\n.r-6koalj{display:flex;}\n.r-bztko3{overflow-x:visible;overflow-y:visible;}\n.r-crgep1{margin:0px;}\n.r-hvic4v{display:none;}\n.r-krxsd3{display:-webkit-box;}\n.r-rs99b7{border-bottom-width:1px;border-left-width:1px;border-right-width:1px;border-top-width:1px;}\n.r-sdzlij{border-bottom-left-radius:9999px;border-bottom-right-radius:9999px;border-top-left-radius:9999px;border-top-right-radius:9999px;}\n.r-t60dpp{padding:0px;}\n.r-wwvuq4{padding:0;}\n.r-xoduu5{display:inline-flex;}\n.r-ywje51{margin:auto;}\n.r-z2wwpe{border-bottom-left-radius:4px;border-bottom-right-radius:4px;border-top-left-radius:4px;border-top-right-radius:4px;}\n[stylesheet-group=\"2.1\"]{}\n.r-1559e4e{padding-bottom:2px;padding-top:2px;}\n.r-1fkl15p{padding-left:32px;padding-right:32px;}\n.r-3o4zer{padding-left:12px;padding-right:12px;}\n.r-3pj75a{padding-left:16px;padding-right:16px;}\n.r-cxgwc0{padding-left:24px;padding-right:24px;}\n.r-dd0y9b{padding-bottom:20px;padding-top:20px;}\n.r-ddtstp{margin-bottom:0px;margin-top:0px;}\n.r-dp7rxi{padding-bottom:40px;padding-top:40px;}\n.r-f8sm7e{margin-left:auto;margin-right:auto;}\n.r-n7gxbd{padding-left:4px;padding-right:4px;}\n.r-s49dbf{margin-bottom:1px;margin-top:1px;}\n.r-sjygvo{padding-left:1em;padding-right:1em;}\n[stylesheet-group=\"2.2\"]{}\n.r-15peodp{right:-9999px;}\n.r-19qo34d{left:-9999px;}\n.r-1ca1ndr{margin-left:0.5em;}\n.r-1ez5h0i{margin-left:4px;}\n.r-1gs4q39{margin-right:4px;}\n.r-1kkk96v{margin-left:8px;}\n.r-1kpi4qh{margin-left:0.075em;}\n.r-1l2kgy{margin-right:0.5em;}\n.r-1q6cnnd{right:-2px;}\n.r-1wron08{margin-right:8px;}\n.r-3t4u6i{margin-left:2px;}\n.r-45ll9u{left:50%;}\n.r-5f1w11{left:-2px;}\n.r-k4bwe5{margin-right:0.075em;}\n.r-o59np7{padding-right:8px;}\n.r-ocobd0{right:50%;}\n.r-qjj4hq{padding-left:8px;}\n.r-x1x4zq{margin-right:2px;}\n[stylesheet-group=\"3\"]{}\n.r-105ug2t{pointer-events:auto!important;}\n.r-109y4c4{height:1px;}\n.r-10ef88u{min-width:700px;}\n.r-10ptun7{height:16px;}\n.r-10v3vxq{transform:scaleX(-1);}\n.r-117bsoe{margin-bottom:20px;}\n.r-11c0sde{margin-top:24px;}\n.r-11f8fnl{background-color:rgba(180,180,182,0.50);}\n.r-11j9u27{visibility:hidden;}\n.r-1202g5r{height:90vh;}\n.r-12181gd{box-shadow:0 0 2px rgba(0,0,0,0.03) inset;}\n.r-1279nm1{min-height:400px;}\n.r-12hfotv{width:700px;}\n.r-12sks89{min-height:22px;}\n.r-12vffkv\u003e*{pointer-events:auto;}\n.r-12vffkv{pointer-events:none!important;}\n.r-12ym1je{width:18px;}\n.r-135wba7{line-height:24px;}\n.r-13qz1uu{width:100%;}\n.r-13wfysu{-webkit-text-decoration-line:none;text-decoration-line:none;}\n.r-146iojx{max-width:300px;}\n.r-1472mwg{height:24px;}\n.r-14j79pv{color:rgba(83,100,113,1.00);}\n.r-14lw9ot{background-color:rgba(255,255,255,1.00);}\n.r-158ssxm{max-height:calc(64px * 15);}\n.r-15ysp7h{min-height:32px;}\n.r-16dba41{font-weight:400;}\n.r-16y2uox{flex-grow:1;}\n.r-176fswd{transform:translateX(-50%) translateY(-50%);}\n.r-1777fci{justify-content:center;}\n.r-17bb2tj{animation-duration:0.75s;}\n.r-17gznlh{animation-name:r-t2lo5v;}\n.r-17leim2{background-repeat:repeat;}\n.r-17s6mgv{justify-content:flex-end;}\n.r-18jsvk2{color:rgba(15,20,25,1.00);}\n.r-18tzken{width:56px;}\n.r-18u37iz{flex-direction:row;}\n.r-18yzcnr{height:22px;}\n.r-19qs0lw{animation-name:r-1qpf3yi;}\n.r-19wmn03{width:20px;}\n.r-19yznuf{min-height:52px;}\n.r-1abnn5w{animation-play-state:paused;}\n.r-1acpoxo{width:36px;}\n.r-1ad0z5i{word-break:break-all;}\n.r-1awozwy{align-items:center;}\n.r-1b43r93{font-size:14px;}\n.r-1betnmo{max-width:672px;}\n.r-1blnp2b{width:72px;}\n.r-1blvdjr{font-size:23px;}\n.r-1ceczpf{min-height:24px;}\n.r-1cwl3u0{line-height:16px;}\n.r-1d2f490{left:0px;}\n.r-1ddef8g{-webkit-text-decoration-line:underline;text-decoration-line:underline;}\n.r-1dn12g7{line-height:48px;}\n.r-1dum35f{-moz-transition-property:opacity, height;-webkit-transition-property:opacity, height;transition-property:opacity, height;}\n.r-1ebb2ja{list-style:none;}\n.r-1ff274t{text-align:right;}\n.r-1ffj0ar{background-color:rgba(0,0,0,0.40);}\n.r-1fu8b7j{height:712px;}\n.r-1g83rmp{animation-name:r-7bj9g2;}\n.r-1gkfh8e{font-size:11px;}\n.r-1h0z5md{justify-content:flex-start;}\n.r-1h8ys4a{padding-top:4px;}\n.r-1habvwh{align-items:flex-start;}\n.r-1hjwoze{height:18px;}\n.r-1iln25a{word-wrap:normal;}\n.r-1inkyih{font-size:17px;}\n.r-1ipicw7{width:300px;}\n.r-1iusvr4{flex-basis:0px;}\n.r-1janqcz{width:16px;}\n.r-1jaylin{width:-webkit-max-content;width:-moz-max-content;width:max-content;}\n.r-1k78y06{font-family:Tahoma, Arial, sans-serif;}\n.r-1kihuf0{align-self:center;}\n.r-1ldzwu0{animation-timing-function:linear;}\n.r-1loqt21{cursor:pointer;}\n.r-1mlwlqe{flex-basis:auto;}\n.r-1mrlafo{background-position:0;}\n.r-1muvv40{animation-iteration-count:infinite;}\n.r-1mwlp6a{height:56px;}\n.r-1nao33i{color:rgba(231,233,234,1.00);}\n.r-1niwhzg{background-color:rgba(0,0,0,0.00);}\n.r-1ny4l3l{outline-style:none;}\n.r-1oifz5y{background-color:rgba(170,17,0,1.00);}\n.r-1oszu61{align-items:stretch;}\n.r-1otgn73{touch-action:manipulation;}\n.r-1p0dtai{bottom:0px;}\n.r-1pi2tsx{height:100%;}\n.r-1pjcn9w{max-width:80vw;}\n.r-1potc6q{top:5%;}\n.r-1ps3wis{min-width:44px;}\n.r-1pz39u2{align-self:stretch;}\n.r-1qd0xha{font-family:-apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif;}\n.r-1qi8awa{min-width:36px;}\n.r-1r5jyh0{min-height:130px;}\n.r-1r8g8re{height:36px;}\n.r-1s2hp8q{min-height:26px;}\n.r-1sxrcry{background-size:auto;}\n.r-1tl8opc{font-family:\"Segoe UI\",Meiryo,system-ui,-apple-system,BlinkMacSystemFont,sans-serif;}\n.r-1to6hqq{background-color:rgba(255,212,0,1.00);}\n.r-1tsuqlv{max-height:100vh;}\n.r-1ttztb7{text-align:inherit;}\n.r-1udbk01{text-overflow:ellipsis;}\n.r-1v2oles{top:50%;}\n.r-1vmecro{direction:rtl;}\n.r-1vr29t4{font-weight:800;}\n.r-1wb8bfx{text-decoration-thickness:2px;}\n.r-1wbh5a2{flex-shrink:1;}\n.r-1wvb978{font-feature-settings:'ss01' on;}\n.r-1wyyakw{z-index:-1;}\n.r-1xcajam{position:fixed;}\n.r-1xfddsp{min-height:300px;}\n.r-1xk2f4g{clip:rect(1px, 1px, 1px, 1px);}\n.r-1xnzce8{-moz-user-select:text;-webkit-user-select:text;user-select:text;}\n.r-1xvli5t{height:1.25em;}\n.r-1y7e96w{min-width:22px;}\n.r-1ye8kvj{max-width:600px;}\n.r-1yef0xd{animation-name:r-11cv4x;}\n.r-1yjpyg1{font-size:31px;}\n.r-1ykxob0{top:60%;}\n.r-2o02ov{margin-top:40px;}\n.r-2tavb8{background-color:rgba(0,0,0,0.60);}\n.r-2yi16{min-height:36px;}\n.r-36ujnk{font-style:italic;}\n.r-37tt59{line-height:32px;}\n.r-3s2u2q{white-space:nowrap;}\n.r-417010{z-index:0;}\n.r-4gszlv{background-size:cover;}\n.r-4hwcpe{font-family:Vazirmatn, Tahoma, Arial, sans-serif;}\n.r-4wgw6l{min-width:32px;}\n.r-54znze{color:rgba(239,243,244,1.00);}\n.r-56xrmm{line-height:12px;}\n.r-6026j{background-color:rgba(255,255,255,0.85);}\n.r-633pao{pointer-events:none!important;}\n.r-6416eg{-moz-transition-property:background-color, box-shadow;-webkit-transition-property:background-color, box-shadow;transition-property:background-color, box-shadow;}\n.r-64el8z{min-width:52px;}\n.r-68jxh1{min-width:500px;}\n.r-7h7f8p{max-width:100vw;}\n.r-7q8q6z{cursor:default;}\n.r-8akbws{-webkit-box-orient:vertical;}\n.r-8jfcpp{top:-2px;}\n.r-92ng3h{width:1px;}\n.r-a023e6{font-size:15px;}\n.r-adyw6z{font-size:20px;}\n.r-agouwx{transform:translateZ(0);}\n.r-ah5dr5\u003e*{pointer-events:none;}\n.r-ah5dr5{pointer-events:auto!important;}\n.r-aqfbo4{backface-visibility:hidden;}\n.r-b88u0q{font-weight:700;}\n.r-bcqeeo{min-width:0px;}\n.r-bnwqim{position:relative;}\n.r-bt1l66{min-height:20px;}\n.r-bvlit7{margin-bottom:-12px;}\n.r-clrlgt{animation-name:r-imtty0;}\n.r-deolkf{box-sizing:border-box;}\n.r-dflpy8{height:1.2em;}\n.r-dnmrzs{max-width:100%;}\n.r-ehq7j7{background-size:contain;}\n.r-emqnss{transform:translateZ(0px);}\n.r-eqz5dr{flex-direction:column;}\n.r-ero68b{min-height:40px;}\n.r-fa1dwr{animation-timing-function:cubic-bezier(0.25, 0.1, 0.25, 1);}\n.r-fdjqy7{text-align:left;}\n.r-fm7h5w{font-family:\"TwitterChirpExtendedHeavy\",\"Verdana\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif;}\n.r-g6jmlv{width:100vw;}\n.r-gf0ln{-webkit-filter:brightness(1);filter:brightness(1);}\n.r-h9hxbl{width:1.2em;}\n.r-htvplk{min-width:600px;}\n.r-icoktb{opacity:0.5;}\n.r-ifefl9{min-height:0px;}\n.r-impgnl{transform:translateX(50%) translateY(-50%);}\n.r-iphfwy{padding-bottom:4px;}\n.r-ipm5af{top:0px;}\n.r-jmul1s{transform:scale(1.1);}\n.r-jwli3a{color:rgba(255,255,255,1.00);}\n.r-kemksi{background-color:rgba(0,0,0,1.00);}\n.r-kwpbio{height:650px;}\n.r-lp5zef{min-width:24px;}\n.r-lrsllp{width:24px;}\n.r-lrvibr{-moz-user-select:none;-webkit-user-select:none;user-select:none;}\n.r-lrx3fh{width:500px;}\n.r-m6rgpd{vertical-align:text-bottom;}\n.r-majxgm{font-weight:500;}\n.r-n1ft60{dynamic-range-limit:standard;}\n.r-n6v787{font-size:13px;}\n.r-nhe8su{animation-duration:0.5s;}\n.r-nvplwv{animation-timing-function:ease-out;}\n.r-nwxazl{line-height:40px;}\n.r-o7ynqc{transition-duration:0.2s;}\n.r-obd0qt{align-items:flex-end;}\n.r-orgf3d{opacity:0;}\n.r-peo1c{min-height:44px;}\n.r-poiln3{font-family:inherit;}\n.r-pp5qcn{vertical-align:-20%;}\n.r-q4m81j{text-align:center;}\n.r-qlhcfr{font-size:0.001px;}\n.r-qvk6io{line-height:0px;}\n.r-qvutc0{word-wrap:break-word;}\n.r-rjixqe{line-height:20px;}\n.r-rki7wi{bottom:12px;}\n.r-rsyp9y{max-height:90vh;}\n.r-s67bdx{font-size:48px;}\n.r-sb58tz{max-width:1000px;}\n.r-tjvw6i{text-decoration-thickness:1px;}\n.r-u6sd8q{background-repeat:no-repeat;}\n.r-u8s1d{position:absolute;}\n.r-ueyrd6{line-height:36px;}\n.r-uho16t{font-size:34px;}\n.r-uz7a3o{min-width:650px;}\n.r-vkv6oe{min-width:40px;}\n.r-vqxq0j{border:0 solid black;}\n.r-vrz42v{line-height:28px;}\n.r-vvn4in{background-position:center;}\n.r-wy61xf{height:72px;}\n.r-x3cy2q{background-size:100% 100%;}\n.r-x572qd{background-color:rgba(247,249,249,1.00);}\n.r-xigjrr{-webkit-filter:blur(4px);filter:blur(4px);}\n.r-yc9v9c{width:22px;}\n.r-yn5ncy{animation-fill-mode:both;}\n.r-yy2aun{font-size:26px;}\n.r-yyyyoo{fill:currentcolor;}\n.r-z2knda{transition-timing-function:ease;}\n.r-z7pwl0{max-width:700px;}\n.r-z80fyv{height:20px;}\n.r-zchlnj{right:0px;}\n@-webkit-keyframes r-11cv4x{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}\n@-webkit-keyframes r-1qpf3yi{0%{opacity:0;transform:scale3d(0.92, 0.92, 1);}100%{opacity:1;transform:scale3d(1, 1, 1);}}\n@-webkit-keyframes r-7bj9g2{0%{opacity:1;transform:scale3d(1, 1, 1);}100%{opacity:0;transform:scale3d(0.92, 0.92, 1);}}\n@-webkit-keyframes r-imtty0{0%{opacity:0;}100%{opacity:1;}}\n@-webkit-keyframes r-t2lo5v{0%{opacity:1;}100%{opacity:0;}}\n@keyframes r-11cv4x{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}\n@keyframes r-1qpf3yi{0%{opacity:0;transform:scale3d(0.92, 0.92, 1);}100%{opacity:1;transform:scale3d(1, 1, 1);}}\n@keyframes r-7bj9g2{0%{opacity:1;transform:scale3d(1, 1, 1);}100%{opacity:0;transform:scale3d(0.92, 0.92, 1);}}\n@keyframes r-imtty0{0%{opacity:0;}100%{opacity:1;}}\n@keyframes r-t2lo5v{0%{opacity:1;}100%{opacity:0;}}\n.r-3x5c00{position:absolute;visibility:hidden;top:0;width:50px;pointer-events:none}\n.r-3x5c00.loaded{visibility:visible;top:50vh;width:50px}\u003c\/style\u003e\n\u003cdiv\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eB-12 MIC | LIPO PURE 10ml Liquid – Research Vial – Research Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eB-12 MIC | LIPO PURE is a research compound blend combining Methylcobalamin (Vitamin B12) with the classic lipotropic agents Methionine, Inositol, and Choline. This formulation is supplied as a ready-to-use liquid solution in a 10ml sealed research vial and is studied for its role in metabolic signaling, fat metabolism, and liver support pathways.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eIn laboratory settings, researchers investigate how this blend influences lipid metabolism, methylation processes, and energy production. Methylcobalamin serves as an active form of B12 involved in neurological and metabolic functions, while Methionine, Inositol, and Choline work synergistically to support fat mobilization, transport, and utilization.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearchers commonly study B-12 MIC | LIPO PURE to explore its potential involvement in:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eLipotropic activity and fat metabolism pathways\u003c\/li\u003e\n\u003cli\u003eLiver detoxification and hepatic lipid processing\u003c\/li\u003e\n\u003cli\u003eMethylation cycles and homocysteine regulation\u003c\/li\u003e\n\u003cli\u003eEnergy production and metabolic efficiency\u003c\/li\u003e\n\u003cli\u003eLipid transport and cholesterol metabolism\u003c\/li\u003e\n\u003cli\u003eSupport for cellular methylation and neurotransmitter synthesis\u003c\/li\u003e\n\u003cli\u003eSynergistic effects of combining B12 with lipotropic compounds on overall metabolic signaling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003eAs a lipotropic research blend, B-12 MIC | LIPO PURE provides a valuable tool for studying metabolic regulation, fat breakdown mechanisms, and nutrient signaling in controlled laboratory environments.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduct Name\u003c\/strong\u003e: B-12 MIC | LIPO PURE\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition\u003c\/strong\u003e: Methylcobalamin (B12) + Methionine + Inositol + Choline\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm\u003c\/strong\u003e: Liquid solution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVolume\u003c\/strong\u003e: 10ml per vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppearance\u003c\/strong\u003e: Clear to slightly colored liquid\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity\u003c\/strong\u003e: \u0026gt;99% (HPLC) – COA available upon request\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e: Store at 2-8°C (refrigerated), protected from light. Do not freeze.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e: Liquid Vial\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Helixera Labs LLC","offers":[{"title":"10ml","offer_id":47335322484913,"sku":null,"price":89.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/b12.jpg?v=1780727745"},{"product_id":"bpc-157-tb-500-transdermal-patches-research-use-only","title":"BPC-157 \/ TB-500 Transdermal Patches","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eBPC-157 \/ TB-500 Transdermal Patches – Research Use Only\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cp dir=\"auto\"\u003eBPC-157 and TB-500 are two of the most extensively studied peptides in preclinical tissue repair and regeneration research. This dual-peptide transdermal patch presentation delivers a blended matrix of both compounds in a format designed for transdermal-delivery research. Each pack contains six individually sealed patches loaded with 500 mcg of each peptide per patch.\u003c\/p\u003e\n\n\u003cp dir=\"auto\"\u003eIn laboratory settings, researchers examine how BPC-157 and TB-500 interact with angiogenic pathways, cell migration mechanisms, and tissue repair models when delivered via a transdermal matrix. The patch format allows for controlled permeation studies and release-kinetics characterization not possible with injectable or oral presentations.\u003c\/p\u003e\n\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearchers commonly study BPC-157 \/ TB-500 transdermal patches to explore:\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eEvaluation of dual-peptide transdermal delivery matrices in vitro\u003c\/li\u003e\n\u003cli\u003ePermeation and release-kinetics characterization of blended peptide systems\u003c\/li\u003e\n\u003cli\u003eCombined BPC-157 and TB-500 effects on tissue repair and angiogenesis pathways\u003c\/li\u003e\n\u003cli\u003eCellular migration models and wound-healing support mechanisms\u003c\/li\u003e\n\u003cli\u003eStability and bioavailability studies of peptide patch substrates\u003c\/li\u003e\n\u003cli\u003eCytoprotective pathway modulation in preclinical research models\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp dir=\"auto\"\u003eAs a combined presentation of two well-characterized repair peptides in a novel delivery format, this patch system serves as a research tool for investigating transdermal peptide pharmacokinetics and tissue-level signaling under controlled laboratory conditions.\u003c\/p\u003e\n\n\u003cp dir=\"auto\"\u003e📄 \u003ca href=\"https:\/\/www.helixerapeptides.com\/pages\/bpc-157-tb-500-wolverine-stack-comprehensive-research-overview-2026\" target=\"_blank\"\u003eRead the Full Research Overview →\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157 Chemical Name\u003c\/strong\u003e: Body Protection Compound-157\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157 CAS Number\u003c\/strong\u003e: 137525-51-0\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157 Molecular Formula\u003c\/strong\u003e: C₆₂H₉₈N₁₆O₂₂\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157 Molecular Weight\u003c\/strong\u003e: ≈1419.5 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500 CAS Number\u003c\/strong\u003e: 77591-33-4\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500 Molecular Formula\u003c\/strong\u003e: C₂₁₂H₃₅₀N₅₆O₇₈S\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit Size\u003c\/strong\u003e: 500 mcg BPC-157 + 500 mcg TB-500 per patch\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuantity\u003c\/strong\u003e: 6 transdermal patches per pack\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity\u003c\/strong\u003e: \u0026gt;99.1% (HPLC) – COA available upon request\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm\u003c\/strong\u003e: Transdermal patch\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppearance\u003c\/strong\u003e: Sealed transdermal matrix patch\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e: Store at 2–8°C, protected from light and moisture. Keep patches sealed until use.\u003c\/p\u003e\n\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eCategory\u003c\/strong\u003e: Transdermal Patch\u003c\/p\u003e\n\n\u003cp dir=\"auto\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u003c\/p\u003e","brand":"Helixera Labs LLC","offers":[{"title":"Default Title","offer_id":47379698057393,"sku":null,"price":120.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/patchbpctb.png?v=1781191333"},{"product_id":"ghk-cu-transdermal-patches-research-use-only","title":"GHK-Cu Transdermal Patches","description":"\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;\u0026lt;strong\u0026gt;GHK-Cu Transdermal Patches – Research Use Only\u0026lt;\/strong\u0026gt;\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;GHK-Cu is a naturally occurring copper-binding tripeptide studied extensively in cellular and preclinical models for its roles in extracellular matrix signaling, copper transport chemistry, and tissue remodeling. This transdermal patch presentation delivers the GHK-Cu complex in a format designed for transdermal-delivery research. Each pack contains ten individually sealed patches loaded with 2000 mcg of GHK-Cu per patch.\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;In laboratory settings, researchers examine how GHK-Cu behaves within transdermal delivery matrices — including permeation characteristics, copper-peptide complex stability in patch substrates, and interactions with skin extracellular matrix models. The patch format enables controlled release and delivery kinetics studies not accessible through standard topical or injectable presentations.\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;\u0026lt;strong\u0026gt;Researchers commonly study GHK-Cu transdermal patches to explore:\u0026lt;\/strong\u0026gt;\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;ul dir=\"auto\"\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;Evaluation of transdermal tripeptide-copper complex delivery matrices in vitro\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;Permeation and release-kinetics characterization of GHK-Cu in patch substrates\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;Copper-peptide complex stability and integrity during transdermal delivery\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;GHK-Cu interactions with skin extracellular matrix and collagen-related pathways\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;Extracellular matrix signaling and tissue remodeling models\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;Comparative bioavailability across delivery formats in research models\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;\/ul\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;As a well-characterized tripeptide-metal complex in a novel delivery format, GHK-Cu transdermal patches serve as a research tool for investigating copper-peptide pharmacokinetics, matrix stability, and tissue-level signaling under controlled laboratory conditions.\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;📄 \u0026lt;a href=\"https:\/\/www.helixerapeptides.com\/pages\/ghk-cu-comprehensive-research-overview-2026\" target=\"_blank\"\u0026gt;Read the Full Research Overview →\u0026lt;\/a\u0026gt;\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;\u0026lt;strong\u0026gt;For laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.\u0026lt;\/strong\u0026gt;\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;h3 dir=\"auto\"\u0026gt;Technical Specifications\u0026lt;\/h3\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;ul dir=\"auto\"\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;Chemical Name\u0026lt;\/strong\u0026gt;: Glycyl-L-histidyl-L-lysine copper(II) complex\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;CAS Number\u0026lt;\/strong\u0026gt;: 89030-95-5\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;Molecular Formula\u0026lt;\/strong\u0026gt;: C₁₄H₂₄N₆O₄Cu\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;Molecular Weight\u0026lt;\/strong\u0026gt;: ≈403.92 g\/mol\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;Unit Size\u0026lt;\/strong\u0026gt;: 2000 mcg per patch\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;Quantity\u0026lt;\/strong\u0026gt;: 10 transdermal patches per pack\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;Purity\u0026lt;\/strong\u0026gt;: \u0026gt;99.1% (HPLC) – COA available upon request\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;Form\u0026lt;\/strong\u0026gt;: Transdermal patch\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;li\u0026gt;\u0026lt;strong\u0026gt;Appearance\u0026lt;\/strong\u0026gt;: Sealed transdermal matrix patch\u0026lt;\/li\u0026gt;\u003cbr\u003e\u0026lt;\/ul\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;\u0026lt;strong\u0026gt;Storage\u0026lt;\/strong\u0026gt;: Store at 2–8°C, protected from light and moisture. Keep patches sealed until use.\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;\u0026lt;strong\u0026gt;Category\u0026lt;\/strong\u0026gt;: Transdermal Patch\u0026lt;\/p\u0026gt;\u003c\/p\u003e\n\u003cp\u003e\u0026lt;p dir=\"auto\"\u0026gt;\u0026lt;strong\u0026gt;Research Use Only.\u0026lt;\/strong\u0026gt; Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.\u0026lt;\/p\u0026gt;\u003c\/p\u003e","brand":"Helixera Labs LLC","offers":[{"title":"Default Title","offer_id":47379699433649,"sku":null,"price":194.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/files\/patchghk.png?v=1781191286"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/5647\/1729\/collections\/372pi.jpg?v=1781282471","url":"https:\/\/www.helixeralabs.com\/es\/collections\/new-in-the-lab.oembed","provider":"Helixera Labs LLC","version":"1.0","type":"link"}